Legal Advantage Investments’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,346
Closed -$203K 81
2026
Q1
$203K Hold
2,346
0.11% 78
2025
Q4
$225K Hold
2,346
0.1% 83
2025
Q3
$223K Sell
2,346
-510
-18% -$46.9K 0.1% 87
2025
Q2
$249K Hold
2,856
0.12% 89
2025
Q1
$257K Sell
2,856
-50
-2% -$4.47K 0.14% 92
2024
Q4
$232K Buy
2,906
+360
+14% +$31.2K 0.12% 97
2024
Q3
$229K Hold
2,546
0.13% 95
2024
Q2
$200K Hold
2,546
0.12% 94
2024
Q1
$222K Hold
2,546
0.12% 100
2023
Q4
$210K Sell
2,546
-25
-1% -$1.91K 0.13% 97
2023
Q3
$201K Buy
+2,571
New +$215K 0.14% 91

Other funds holding MDT

Legal Advantage Investments's MDT Position: Q2 2026 in Review

Legal Advantage Investments sold out of Medtronic (MDT) in Q2 2026, closing a stake of 2,346 shares — an estimated $203K sold.

Legal Advantage Investments first reported a position in MDT in Q3 2023 and held it in 11 quarters. The position peaked at $257K in Q1 2025. 961 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Legal Advantage Investments reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
  • Legal Advantage Investments sold 2,346 Medtronic shares in Q2 2026, an estimated $203K.
  • Legal Advantage Investments first reported a position in Medtronic in Q3 2023 and held it in 11 quarters.
  • Legal Advantage Investments's Medtronic position peaked at $257K in Q1 2025.
  • 961 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Legal Advantage Investments's 13F filing for Q2 2026, filed 15 Jul 2026.